SEARCH

SEARCH BY CITATION

References

  • Bacigalupo, A., Bruno, B., Saracco, P., Di Bona, E., Locascuilli, A., Locatelly, F., Gabbas, A., Dufour, C., Arcese, W., Testi, G., Broccia, G., Marotenuto, M., Coser, P., Barbui, T., Leoni, P. & Ferster, A.for the European Group for Blood and Marrow Transplantation (EBMT) Working Party on Severe Aplastic Anaemia and the Gruppo Italiano Trapianti di Midollo Oseeo (GITMO) (2000a) Antilymphocyte globulin, cyclosporine, prednisolone and granulocyte stimulating factor for severe aplastic anaemia: an update of the GITMO/EBMT study on 100 patients. Blood, 95, 19311933.
  • Bacigalupo, A., Brand, R., Oneto, R., Bruno, B., Socie, G., Passweg, J., Locasciulli, A., Van Lint, M.T., Tichelli, A., McCann, S., Marsh, J., Ljungman, P., Hows, J., Marin, P. & Schrezenmeier, H. (2000b) Treatment of acquired severe aplastic anaemia: bone marrow transplantation compared with immunosuppressive therapy – the European Group for Blood and Marrow Transplantation experience. Seminars in Haematology, 37, 6980.
  • Bacigalupo, A., Locatelli, F., Socie, G., Dini, G., Pession, A., Locasciulli, A., Prete, A. & Schrezenmeier, H. (2002) Fludarabine, cyclophosphamide and ATG for alternative donor transplants in aplastic anaemia – a report of the SAA Working Party. Bone Marrow Transplantation, 29(Suppl. 2), 312a.
  • Brodsky, R.A., Sensenbrenner, L.L., Smith, B.D., Dorr, D., Seaman, P.J., Karp, J.E., Brodsky, I. & Jones, R.J. (2001) Durable treatment-free remission following high dose cyclophosphamide for previously untreated severe aplastic anaemia. Annals of Internal Medicine, 135, 477483.
  • Tisdale, J.F., Dunn, D.E., Geller, N., Plante, M., Nunez, O., Dunbar, C.E., Barrett, A.J., Walsh, T.J., Rosenfeld, S.J. & Young, N.S. (2000) High dose cyclophosphamide in severe aplastic anaemia: a randomised trial. Lancet, 356, 15541559.
  • Tisdale, J.F., Maciejewski, J.P., Nunez, O., Rosenfeld, S.J. & Young, N.S. (2002) Late complications following treatment for severe aplastic anaemia (SAA) with high-dose cyclophosphamide (Cy): follow up of a randomised trial. Blood, 100, 46684670.